Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma

Keichiro Mihara, Kazuyoshi Yanagihara, Misato Takigahira, Akira Kitanaka, Chihaya Imai, Joyeeta Bhattacharyya, Takanori Kubo, Yoshifumi Takei, Shin'Ichiro Yasunaga, Yoshihiro Takihara, Akiro Kimura

Research output: Contribution to journalArticle

26 Citations (Scopus)

Fingerprint Dive into the research topics of 'Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences